Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL713217 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL715364 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL712408 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL713038 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL716379 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL403954 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL720226 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL715943 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| Water SCHEMBL15939211 | 0.98 | TSHR (0.38) | TSHRKDM4ETDP1USP2MAPT | |
| Ammonia Solution, Strong SCHEMBL6997853 | 0.98 | TSHR (0.38) | TSHRKDM4ETDP1USP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119286386-A | Elastic base material for automobile spraying coating, and preparation method and application thereof | 广州波粒新材料科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119080010-A | Preparation method and application of organic fluorine modified nano fumed silica | 湖北汇富纳米材料股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118483343-A | Method for simultaneously detecting multiple new pollutants in coral | 广东省环境科学研究院 | 2024-08-13 | — | — | CN | claimed |
| CN-118461044-A | MOF hydrophobic microenvironment regulation ruthenium nanoparticle catalyst and preparation method and application thereof | 中国科学院合肥物质科学研究院 | 2024-08-09 | — | — | CN | claimed |
| CN-111848832-B | Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof | 苏州大学 | 2024-02-20 | — | — | CN | claimed |
| CN-111892667-B | Application of fluorine-containing compound modified cationic polymer in preparation of medical cosmetic and health care products | 苏州大学 | 2024-02-20 | — | — | CN | claimed |
| CN-111848831-B | Application of fluorine-containing compound modified cationic polymer in preparation of vaccine medicine | 苏州大学 | 2023-06-13 | — | — | CN | claimed |
| CN-115475607-A | Cationic amphiphilic fluorine-containing hydrogel adsorbent and preparation method and application thereof | 安徽农业大学 | 2022-12-16 | — | — | CN | claimed |
| EP-4095162-A1 | APPLICATION OF AND PREPARATION METHOD FOR CATIONIC POLYMER MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER | Soochow University (CN) | 2022-11-30 | — | — | EP | claimed |
| US-20220273806-A1 | USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD | SOOCHOW UNIVERSITY (CN) | 2022-09-01 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1431984-A1 | Polymer resistor composition having a substantially neutral temperature coefficient of resistance and methods and compositions relating thereto | E. I. du Pont de Nemours and Company (US) | 2004-06-23 | — | — | EP | claimed |
| US-20040113127-A1 | Resistor compositions having a substantially neutral temperature coefficient of resistance and methods and compositions relating thereto | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-06-17 | — | — | US | claimed |
| US-20030099424-A1 | Optical gain media and methods for making and using same | MOHAJER YOUSEF (US) | 2003-05-29 | — | — | US | claimed |
| WO-2003018592-A1 | OPTICAL GAIN MEDIA | PHOTON-X, INC. (US) | 2003-03-06 | — | — | WO | claimed |
| EP-1288727-A2 | Polydimethylsiloxane and fluorosurfactant fusing release agent | Xerox Corporation (US) | 2003-03-05 | — | — | EP | claimed |
| US-6515069-B1 | A release agent having a polydimethylsiloxane and a fluorosurfactant other than a silicone glycol polymer, a perfluoroalkylsubstituted polyethylene glycol, or a perfluoroalkylsubstituted silane. | XEROX CORPORATION | 2003-02-04 | — | — | US | claimed |
| US-6383274-B1 | Ink jet ink compositions and printing processes | XEROX CORPORATION | 2002-05-07 | — | — | US | claimed |
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273806-A1 | USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD | F12, SLCO4C1, SLC7A1 | TSHR 111/4885KDM4E 989/4885TDP1 4195/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | TSHR 4082/4885KDM4E 1567/4885TDP1 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.